Zhong Yuan Bio-technology Holdings Ltd. Stock Analysis ZHYBF
Zhong Yuan Bio-Technology Holdings Ltd. engages in the research and development of early detection kits for brain diseases, plant-derived nervonic acid health supplements and new drugs for neurological diseases. The company employs 23 full-time employees The company went IPO on 2021-03-05. The firm operates its business through two segments. The Sales of Health Care Supplements segment is engaged in the development and sale of new drugs for neurological disorders, brain disease detection kits, the sale of plant-derived nervonic acid health supplements as well as others. The firm's main products are nervonic acid series supplements, marketed under the 'Muzhiyuan Neuro Enhancer' brand. The Technical Supporting Services segment is engaged in the provision of technical services.
Read More Zhong Yuan Bio-technology Holdings Ltd (ZHYBF) Chart
Financial Metrics & Statements of Zhong Yuan Bio-technology Holdings Ltd (ZHYBF)
FAQ's for Zhong Yuan Bio-technology Holdings Ltd (ZHYBF)
- According to Musaffa’s Shariah screening methodology, Zhong Yuan Bio-technology Holdings Ltd (ZHYBF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.